One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

Memorial Sloan Kettering Cancer Center is proud to announce the formation of MSK Ventures, a dedicated venture capital fund launching in 2026. MSK Ventures is designed to invest in high-conviction ...

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year agreement ...

In late June 2025, a rumor circulated that U.S. health insurance company UnitedHealthcare (UHC) had stopped covering treatment at Memorial Sloan Kettering Cancer Center, the world-renowned cancer care ...